Cite
HARVARD Citation
Abida, W. et al. (n.d.). 793PDPreliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations. Annals of oncology. p. . [Online].